36.43MMarket Cap-571P/E (TTM)
0.895High0.865Low47.60KVolume0.890Open0.875Pre Close41.79KTurnover0.21%Turnover RatioLossP/E (Static)41.75MShares3.16052wk High-3.28P/B19.64MFloat Cap0.80052wk Low--Dividend TTM22.51MShs Float51.357Historical High--Div YieldTTM3.41%Amplitude0.800Historical Low0.877Avg Price1Lot Size
Carisma Therapeutics Stock Forum
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
Carisma Therapeutics (NASDAQ: CARM) presented promising preclinical data on engineered macrophages for treating liver fibrosis at AASLD The Liver Meeting® 2024. The research shows that macrophages can be genetically engineered to target specific pathways in liver disease using factors like TIM4, relaxin, an...
Will you ever get your ass up? 😭 😭 😭
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Carisma Therapeutics (NASDAQ: CARM) announced positive pre-clinical data for its anti-GPC3 in vivo CAR-M therapy for hepatocellular carcinoma (HCC), developed with Moderna. The therapy demonstrated ability to create CAR-M directly in vivo, reprogramming myeloid cells to target GPC3-expressing cancer cells. Pre-clinical results showed specificity fo...
Moderna news / collaboration.
Yet no movement. 🧐🤔
Carisma and Moderna Expand Collaboration to Develop Two in Vivo Car-M Therapies for Autoimmune Diseases
$Cosmos Health (COSM.US)$ $African Agriculture (AAGR.US)$ $Innovative Eyewear (LUCY.US)$ $Carisma Therapeutics (CARM.US)$ $Ocean Power Technologies (OPTT.US)$
📊⚡️📊
No comment yet